Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON24479Recruiting
Trial of adalimumab and methotrexate in plaque psoriasis (2 arms), sponsored by Academic Medical Center. Primary endpoint: Drug survival at 1 year. Started Mar 2014; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON24479.